Novavax (NVAX), SK bioscience Announce Collaboration for Novavax' COVID-19 Vaccine Candidate

Go back to Novavax (NVAX), SK bioscience Announce Collaboration for Novavax' COVID-19 Vaccine Candidate

Novavax and SK bioscience Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate

August 13, 2020 8:31 AM EDT

SK bioscience to manufacture antigen component of NVX-CoV2373
Builds on and complements Novavax-CEPI collaboration to develop and distribute NVX-CoV2373Novavax, SK bioscience and Republic of Korea intend to partner for manufacture and supply of vaccine for global markets including South Korea

GAITHERSBURG, Md. and SEOUL, South Korea, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, and SK bioscience, a vaccine business subsidiary of SK Group, today announced a... More